European Stocks Possibly Trading Below Estimated Value May 2026

As the European market navigates through a landscape marked by stable interest rates and geopolitical uncertainties, the pan-European STOXX Europe 600 Index has managed to maintain a steady course, reflecting cautious optimism amid positive earnings momentum. In this environment, identifying potentially undervalued stocks becomes crucial for investors seeking opportunities that may offer value relative to their estimated worth.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name Current Price Fair Value (Est) Discount (Est) Sinch (OM:SINCH) SEK33.10 SEK64.21 48.4% Serviceware (XTRA:SJJ) €11.70 €23.31 49.8% RaySearch Laboratories (OM:RAY B) SEK185.40 SEK361.60 48.7% Metriks AI. Società Benefit (BIT:MTK) €3.66 €7.17 48.9% Haypp Group (OM:HAYPP) SEK124.40 SEK241.56 48.5% EBRO EV Motors (BME:EBROM) €10.10 €19.96 49.4% Dometic Group (OM:DOM) SEK30.86 SEK61.55 49.9% DNO (OB:DNO) NOK19.88 NOK39.50 49.7% Coloplast (CPSE:COLO B) DKK404.50 DKK802.06 49.6% B&S Group (ENXTAM:BSGR) €5.85 €11.66 49.8%

Click here to see the full list of 191 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Let's dive into some prime choices out of the screener.

Sartorius Stedim Biotech

Overview: Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry globally, with a market cap of €15.80 billion.

Operations: The company generates revenue of €2.98 billion from its biopharmaceutical segment, focusing on instruments and consumables for the industry worldwide.

Estimated Discount To Fair Value: 14.8%

Sartorius Stedim Biotech is trading at €162.4, below its estimated future cash flow value of €190.61, indicating potential undervaluation based on cash flows. Despite high debt levels, the company shows strong earnings growth prospects, with a forecasted annual increase of 20.8%, outpacing the French market's 12.3%. Recent earnings reports reveal steady revenue and income growth, supporting its financial health and reinforcing its appeal as an undervalued stock in Europe.

Our expertly prepared growth report on Sartorius Stedim Biotech implies its future financial outlook may be stronger than recent results. Click here to discover the nuances of Sartorius Stedim Biotech with our detailed financial health report.ENXTPA:DIM Discounted Cash Flow as at May 2026

Outokumpu Oyj

Overview: Outokumpu Oyj is a company that produces and sells stainless steel products across Europe, North America, the Asia-Pacific, and internationally, with a market cap of approximately €2.76 billion.

Operations: The company's revenue is primarily derived from its Europe segment at €3.60 billion, followed by the Americas at €1.68 billion, and Ferrochrome contributing €462 million.

Story Continues

Estimated Discount To Fair Value: 25.7%

Outokumpu Oyj is trading at €5.85, significantly below its estimated future cash flow value of €7.87, suggesting it may be undervalued based on cash flows. Despite a volatile share price and forecasted low return on equity of 7.2% in three years, the company is expected to become profitable with earnings projected to grow by over 50% annually, surpassing average market growth rates and indicating good relative value compared to peers and industry benchmarks.

In light of our recent growth report, it seems possible that Outokumpu Oyj's financial performance will exceed current levels. Click here and access our complete balance sheet health report to understand the dynamics of Outokumpu Oyj.HLSE:OUT1V Discounted Cash Flow as at May 2026

RENK Group

Overview: RENK Group AG specializes in the design, engineering, production, testing, and servicing of customized drive systems across several regions including Asia, Germany, the United States, Africa, Australia, Oceania, and various European countries with a market cap of €5.53 billion.

Operations: The company's revenue is derived from three main segments: Slide Bearings (€127.88 million), Marine & Industry (€380.42 million), and Vehicle Mobility Solutions (€872.22 million).

Estimated Discount To Fair Value: 34.9%

RENK Group is trading at €55.26, significantly below its estimated future cash flow value of €84.88, highlighting potential undervaluation based on cash flows. The company reported strong financial performance with net income doubling to €100.36 million in 2025 and earnings per share rising to €1. Revenue growth is expected to outpace the German market at 15.2% annually, while earnings are forecasted to grow by over 23% yearly, despite a high debt level.

The growth report we've compiled suggests that RENK Group's future prospects could be on the up. Delve into the full analysis health report here for a deeper understanding of RENK Group.XTRA:R3NK Discounted Cash Flow as at May 2026

Next Steps

Investigate our full lineup of 191 Undervalued European Stocks Based On Cash Flows right here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Ready For A Different Approach?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ENXTPA:DIM HLSE:OUT1V and XTRA:R3NK.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments